FT News Feed

Drew Mariani and Father Tad discuss a new and expensive treatment for sickle cell anemia which relies on the genetic modification of blood-producing stem cells using CRISPR. They discuss whether CRISPR can be misused as a technique, and how treatments that are based on using a patient's own stem cells can offer a hopeful path into the future in the face of a difficult and painful disease like sickle cell anemia.

 See CRISPR

Segment begins at 16:15: